Cargando…
Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer
Urothelial Cancer - Genomic Analysis to Improve Patient Outcomes and Research (NCT02643043), UC-GENOME, is a genomic analysis and biospecimen repository study in 218 patients with metastatic urothelial carcinoma. Here we report on the primary outcome of the UC-GENOME—the proportion of subjects who r...
Autores principales: | Damrauer, Jeffrey S., Beckabir, Wolfgang, Klomp, Jeff, Zhou, Mi, Plimack, Elizabeth R., Galsky, Matthew D., Grivas, Petros, Hahn, Noah M., O’Donnell, Peter H., Iyer, Gopa, Quinn, David I., Vincent, Benjamin G., Quale, Diane Zipursky, Wobker, Sara E., Hoadley, Katherine A., Kim, William Y., Milowsky, Matthew I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636269/ https://www.ncbi.nlm.nih.gov/pubmed/36333289 http://dx.doi.org/10.1038/s41467-022-33980-9 |
Ejemplares similares
-
Emerging biomarkers in urothelial carcinoma: Challenges and opportunities
por: Andreatos, Nikolaos, et al.
Publicado: (2020) -
Bladder Cancer Patient Advocacy: A Global Perspective
por: Quale, Diane Zipursky, et al.
Publicado: (2015) -
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer
por: Galsky, Matthew D, et al.
Publicado: (2021) -
Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think Tank
por: Kamat, Ashish M., et al.
Publicado: (2016) -
Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status
por: Grivas, Petros, et al.
Publicado: (2020)